A detailed history of Affinity Asset Advisors, LLC transactions in Repare Therapeutics Inc. stock. As of the latest transaction made, Affinity Asset Advisors, LLC holds 173,351 shares of RPTX stock, worth $234,023. This represents 0.1% of its overall portfolio holdings.

Number of Shares
173,351
Holding current value
$234,023
% of portfolio
0.1%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$2.75 - $3.99 $476,715 - $691,670
173,351 New
173,351 $596,000
Q2 2022

Aug 12, 2022

SELL
$8.45 - $14.84 $1.25 Million - $2.19 Million
-147,705 Reduced 31.5%
321,200 $4.49 Million
Q1 2022

May 13, 2022

BUY
$11.38 - $21.88 $2.24 Million - $4.31 Million
197,127 Added 72.53%
468,905 $6.68 Million
Q4 2021

Feb 11, 2022

BUY
$19.66 - $28.11 $5.34 Million - $7.64 Million
271,778 New
271,778 $5.73 Million

Others Institutions Holding RPTX

About Repare Therapeutics Inc.


  • Ticker RPTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,937,800
  • Market Cap $56.6M
  • Description
  • Repare Therapeutics Inc., a clinical-stage precision oncology company, discovers and develops therapeutics by using its synthetic lethality approach in Canada and the United States. The company uses its SNIPRx, a proprietary, genome-wide, and CRISPR-enabled platform to systematically discover and develop highly targeted cancer therapies that foc...
More about RPTX
Track This Portfolio

Track Affinity Asset Advisors, LLC Portfolio

Follow Affinity Asset Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Affinity Asset Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Affinity Asset Advisors, LLC with notifications on news.